Osman Sütcüoğlu; Orhun Akdoğan; İlknur Deliktaş Onur; Atilla Çiftçi; Ali Alkan; Nargiz Majidova; Elif Şahin; Gül Sema Yıldıran; Elif Şenocak Taşçı; Gözde Kavgacı; Ömer Genç; Mehmet Sıddık Dilek; Nilgün Özbek Okumuş; Fariz Emrah Özkan; Oğuzhan Selvi; Hasibe Bilgi Gür; Serhat Sekmek; Fatih Karataş; Şafak Yıldırım Dişli; Nilüfer Avcı; Serkan Menekşe; Mert Erciyestepe; Engin Kut; Süleyman Alkan; Mustafa Ersoy; Ali İnal; Ali Murat Tatlı; Ferit Aslan; Emine Türkmen; Didem Çolpan Öksüz; Teoman Şakalar; Sabin Göktaş Aydın; Gülhan Özkanlı; Abdullah Sakin; Bahiddin Yılmaz; Ali Kaan Güren; Musa Barış Aykan; Fahriye Tuğba Köş; Murat Araz; Atike Pınar Erdoğan; İlhan Hacıbekiroğlu; İbrahim Yıldız; Muhammet Ali Kaplan; Hacer Demir; Suayib Yalçın; Ömer Dizdar; Özgür Tanrıverdi; Dılşa Mızrak Kaya; Mutlu Doğan; Nuriye Özdemir

Modified Aarhus Composite Biomarker Score as a New Risk-Stratification Tool in Metastatic Colorectal Cancer

改良的奥斯陆综合生物标志物评分作为转移性结直肠癌的新风险分层工具

Diagnostics

IF3.3

2026-03-130

OAAI

Contrast-Enhanced Mammography vs. Breast MRI for Assessing Neoadjuvant Chemotherapy Response: A Prospective Clinical Comparison Study

对比增强乳腺摄影与乳腺MRI在评估新辅助化疗反应中的比较：一项前瞻性临床对比研究

Diagnostics

IF3.3

2026-02-270

OAAI

Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG)

葡萄膜黑色素瘤的真实治疗模式和生存率: 土耳其肿瘤学组 (TOG) 的一项多中心队列研究

Cancers

IF4.4

2026-01-280

Sercan On; Selin Cebeci; Zeynep Hande Turna; Zeynep Gülsüm Güç Sevgen; Deniz Can Guven; Sadettin Kılıçkap; Mehmet Nuri Başer; Bilgin Demir; Sedat Biter; Ertuğrul Bayram; Berkay Yeşilyurt; Doğan Uncu; Ahmet Melih Arslan; Elif Atağ Akyürek; Hayati Arvas; Zuhat Urakçı; Teoman Şakalar; Ferit Aslan; Mehmet Uzun; Mustafa Yıldırım; Ahmet Unlu; Derya Kıvrak Salim; Atike Pınar Erdoğan; Elif Sahin; Şeyda Gündüz; Burcu Gülbağcı; Şaziye Burçak Karaca Yayla; Burcu Cakar

Nephrotoxicity secondary to CDK 4/6 inhibitors in advanced breast cancer patients and its impact on survival

CDK 4/6抑制剂引起的肾毒性及其对晚期乳腺癌患者生存的影响

Therapeutic Advances in Medical Oncology

IF4.2

2026-01-090

Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety

CDK4/6抑制剂治疗转移性乳腺癌患者的生存率影响因素：ER表达水平和治疗初治性的重要性

Current Oncology 2025, Vol. 32, Page 709

IF3.4

2025-12-170

OAAI

Survival outcomes and recurrence patterns of early-stage HER2-positive breast cancer patients on adjuvant T-DM1 treatment: Turkish Oncology Group (TOG) Study

早期HER2阳性乳腺癌患者接受辅助T-DM1治疗的生存结局与复发模式：土耳其肿瘤学组（TOG）研究

Clinical Breast Cancer

IF2.5

2025-12-010

PRE

The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre study

靶向疗法在肺鳞状细胞癌转移中的疗效：一项土耳其肿瘤学组多中心研究

JOURNAL OF CHEMOTHERAPY

IF1.8

2025-12-010

PRE

Kilictas, Bilgesah; Araz, Murat; Oruc, Ahmet; Caglayan, Dilek; Emin, Gamze; Yildirim, Atila; Aydin, Tayyip Ilker; Hacioglu, Muhammet Bekir; Disli, Ahmet Kursad; Inanc, Mevlude; Uyar, Galip Can; Cakmak Oksuzoglu, Omur Berna; Uysal, Mukremin; Kocanoglu, Abdulkadir; Akin Telli, Tugba; Akdag, Goncagul; Kinikoglu, Oguzcan; Isik, Deniz; Arcagok, Murat; Urakci, Zuhad; Sahin, Elif; Akdogan, Orhun; Danaci, Yurdagul; Sakalar, Teoman; Avci, Nilufer; Serin Ozel, Gamze; Dogu, Gamze Gokoz; Sahin Hafizoglu, Ece; Erdogan, Atike Pinar; Alkan, Ali; Erkan Ozmarasali, Buket; Deligonul, Adem; Buyuksimsek, Mahmut; Karakurt Eryilmaz, Melek; Artac, Mehmet

Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival

慢性肾病与地诺单抗在骨转移性疾病中的应用：一项关于严重低钙血症、骨骼事件和生存情况的多中心土耳其队列研究

Journal of Bone Oncology

IF3.5

2025-11-210

OAAI

SIRI as a Prognostic Marker in Metastatic Pancreatic Cancer

SIRI作为转移性胰腺癌的预后标志物

MEDICINA-LITHUANIA

IF2.4

2025-11-120